Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis-Solid Tumors

Role of FDG-PET in the diagnosis of recurrent and metastatic lesions of malignant testicular tumors

Tevfik Cermik, Ayse Mavi, Gunsel Acikgoz, Simin Dadparvar and Abass Alavi
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 377P;
Tevfik Cermik
1Radiology-Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse Mavi
2Nuclear Medicine, Yeditepe University Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunsel Acikgoz
1Radiology-Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simin Dadparvar
1Radiology-Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
1Radiology-Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 48 no. supplement 2 377P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online October 31, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Tevfik Cermik1,
  2. Ayse Mavi2,
  3. Gunsel Acikgoz1,
  4. Simin Dadparvar1 and
  5. Abass Alavi1
  1. 1Radiology-Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania;
  2. 2Nuclear Medicine, Yeditepe University Hospital, Istanbul, Turkey

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2015 to April 2025

AbstractFullPdf
Mar 2015100
Apr 2015300
Jul 2015200
Sep 2015200
Nov 2015400
Feb 2016100
Oct 2016100
Mar 2017100
May 2017200
Jun 2017300
Jul 2017100
Aug 2017200
Dec 2017500
Jul 2018100
Mar 2019400
May 2019200
Aug 2019100
Nov 2019200
Jan 2020100
Feb 2020100
Aug 2020100
Dec 2020100
Feb 20211000
Mar 2021600
Apr 2021700
May 2021800
Jun 2021200
Jul 2021200
Aug 2021200
Sep 2021400
Oct 2021200
Nov 2021200
Dec 2021400
Jan 2022200
Feb 2022800
Mar 2022100
Apr 2022100
May 2022100
Jun 2022200
Jul 20221700
Aug 2022200
Sep 2022100
Mar 2023100
May 2023300
Jun 2023100
Jul 2023200
Aug 2023200
Sep 2023100
Oct 2023200
Nov 2023500
Dec 2023200
Jan 2024500
Feb 2024200
Mar 2024300
May 2024500
Jul 2024200
Aug 2024700
Sep 20241000
Oct 2024300
Nov 2024500
Dec 2024400
Feb 2025200
Mar 2025200
Apr 2025300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of FDG-PET in the diagnosis of recurrent and metastatic lesions of malignant testicular tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of FDG-PET in the diagnosis of recurrent and metastatic lesions of malignant testicular tumors
Tevfik Cermik, Ayse Mavi, Gunsel Acikgoz, Simin Dadparvar, Abass Alavi
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 377P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of FDG-PET in the diagnosis of recurrent and metastatic lesions of malignant testicular tumors
Tevfik Cermik, Ayse Mavi, Gunsel Acikgoz, Simin Dadparvar, Abass Alavi
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 377P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis-Solid Tumors

  • Prognosis and stage shift of patients with cancer detected on multimodal cancer screening including FDG-PET
  • PET/CT in the evaluation of treatment response and follow-up in patients with ovarian carcinoma
  • The relationship of 18F-FDG uptake and glucose transporter-1,3 expression in primary cancer of uterus
Show more Oncology: Clinical Diagnosis-Solid Tumors

Clinical Diagnosis-Solid Tumors Posters

  • 68Ga-DOTATOC PET/CT and 90Y-DOTATOC therapy: Perspectives for patients with metastatic radioiodine negative differentiated thyroid cancer
  • Comparison of distribution of FDG and Cu-62 ATSM in head and neck cancer
  • Changes in metabolic activity of malignant pleural mesothelioma on dual time point FDG-PET
Show more Clinical Diagnosis-Solid Tumors Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire